Product Information
DEPAKOTE DR 125 MG SPRINKLE CP is a brand product labeled by AbbVie Inc., priced at $1.9659 per EA under NDC 00074611413. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 12, 1989. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Divalproex Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
125 mg/1
Manufacturer
AbbVie Inc.NDC
00074611413
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA019680FDA Approved
9/12/1989
TE Code
AB
On Market Since
9/12/1989
Pharmacological Classes
Price Statistics
The NADAC for DEPAKOTE DR 125 MG SPRINKLE CP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 76.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9659 per EA |
|---|---|
| All-time high | $1.9719 (May 13, 2026) |
| All-time low | $1.1134 (Nov 28, 2013) |
| 52-week high | $1.9719 |
| 52-week low | $1.8780 |
| Median price | $1.6205 |
| Average price | $1.6083 |
| Largest weekly change | +9.9% (Jan 8, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Divalproex Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEPAKOTE DR 125 MG SPRINKLE CP?
The current National Average Drug Acquisition Cost (NADAC) for DEPAKOTE DR 125 MG SPRINKLE CP, manufactured by AbbVie Inc., is $1.9659 per EA (NDC 00074611413), effective Aug 19, 2026.
How has the price of DEPAKOTE DR 125 MG SPRINKLE CP changed over time?
Over the history we have for it, the NADAC for DEPAKOTE DR 125 MG SPRINKLE CP has risen 76.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEPAKOTE DR 125 MG SPRINKLE CP?
Since Nov 28, 2013, the NADAC for DEPAKOTE DR 125 MG SPRINKLE CP has ranged from a low of $1.1134 (Nov 28, 2013) to a high of $1.9719 (May 13, 2026), with a median of $1.6205 per EA.
Are there cheaper alternatives to DEPAKOTE DR 125 MG SPRINKLE CP?
No other NADAC-published product currently shares the active ingredient and strength of DEPAKOTE DR 125 MG SPRINKLE CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEPAKOTE DR 125 MG SPRINKLE CP?
DEPAKOTE DR 125 MG SPRINKLE CP (NDC 00074611413) is labeled by AbbVie Inc., and CMS classifies it as a brand product.